^
    Apply
    A Study of BNC105P Combined With Ibrutinib (NCT03454165)
    Phase 1
    Dartmouth-Hitchcock Medical Center
    Completed
    Last update posted :
    01/04/2023
    Initiation :
    03/09/2018
    Primary completion :
    01/14/2021
    Completion :
    01/14/2021
    BCL2 • CCND1 • CD5 • FCER2
    |
    Chr t(11;14) • CCND1 overexpression
    |
    Imbruvica (ibrutinib) • BNC105